Stock option plan
2+ days a week in office
Protein engineering platform
Open for applications
Protein engineering platform
21-100 employees
Open for applications
Stock option plan
2+ days a week in office
21-100 employees
To accelerate the discovery of next-generation therapeutic antibodies.
LabGenius's protein engineering platform integrates several technologies from the fields of machine learning, synthetic biology, and robotics. It uses computational methods to explore protein fitness landscapes and improve multiple drug properties simultaneously.
The discovery of protein therapeutics has historically been highly artisanal, relying heavily on humans for both experimental design and execution. This dependence is limiting because, as a species, we’re cognitively incapable of fully grasping the complexity of biological systems. LabGenius is pushing the boundaries of protein engineering through the development of EVA - a smart robotic platform capable of designing, conducting and critically, learning from its own experiments. The learning aspect means that EVA gets continuously smarter as it unpicks the genetic design rules that underpin life.
LabGenius is deploying EVA to develop novel antibody fragments in therapeutic areas, including solid tumours, where there's a distinct advantage over traditional antibody formats. EVA engineers high-value protein drug properties that currently remain a challenge, such as efficacy, potency, selectivity, and manufacturability.
The team at LabGenius are excited by this rapid experimentation and are looking at how the same principles can be applied more widely to find treatments for human diseases.
Kirsty
Company Specialist at Welcome to the Jungle
Opportunities to learn
"Everyone in the company is given a generous budget to use towards books, courses and events to help them grow both professionally and personally...."
Apr 2024
$46m
SERIES B
Jan 2022
$1.4m
GRANT
Bermondsey, London, UK
James Field
(CEO)Earned a Bachelor of Science degree in Biology and Microbiology, a Master of Science degree in Systems and Synthetic Biology and a PhD in Synthetic Biology from Imperial.
Joined as Office & Operations Manager, being promoted to People Operations Manager after 7 months. As of November 2021, they're working as a Senior People Partner.
Alex joined LabGenius as a Software Engineer in November 2020. In January 2023 Alex was promoted to Associate Principal Software Engineer as the functional lead of the team.
Share this job